D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 49 Citations 14,130 107 World Ranking 3437 National Ranking 63

Overview

What is he best known for?

The fields of study he is best known for:

  • DNA
  • Virus
  • Antibody

Yuxian He spends much of his time researching Virology, Antibody, Coronavirus, Virus and Epitope. His Virology research includes themes of Molecular biology, Microbiology and BALB/c. His research in the fields of Antiserum overlaps with other disciplines such as Protein subunit.

His Virus research includes elements of Multiple drug resistance and In vivo. His work focuses on many connections between Epitope and other disciplines, such as Neutralization, that overlap with his field of interest in Monoclonal antibody, Binding site and Antigen. His work in Transmembrane protein addresses issues such as Glycoprotein, which are connected to fields such as Biophysics, Heptad repeat, Circular dichroism and Peptide.

His most cited work include:

  • The spike protein of SARS-CoV — a target for vaccine and therapeutic development (791 citations)
  • Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response (525 citations)
  • Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. (340 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Virology, Antibody, Gp41, Coronavirus and Peptide. His study in Virology focuses on Virus in particular. The study incorporates disciplines such as Receptor, Microbiology and Lentivirus in addition to Virus.

His work deals with themes such as Molecular biology and Antigen, which intersect with Antibody. His Gp41 research is multidisciplinary, relying on both Biochemistry, Lipid bilayer fusion, Cell fusion and Heptad repeat. His Peptide research incorporates themes from Mechanism of action, Leucine, Structure–activity relationship, Computational biology and In vivo.

He most often published in these fields:

  • Virology (73.45%)
  • Antibody (46.90%)
  • Gp41 (39.82%)

What were the highlights of his more recent work (between 2016-2021)?

  • Virology (73.45%)
  • Gp41 (39.82%)
  • Lipid bilayer fusion (18.58%)

In recent papers he was focusing on the following fields of study:

Yuxian He mainly focuses on Virology, Gp41, Lipid bilayer fusion, Enfuvirtide and Lipopeptide. His biological study spans a wide range of topics, including Epitope, Antibody and Lipid raft. His Epitope study integrates concerns from other disciplines, such as Cytotoxic T cell, MHC class I and Monoclonal antibody.

His specific area of interest is Antibody, where Yuxian He studies Neutralizing antibody. His research in Gp41 tackles topics such as Peptide which are related to areas like Heptad repeat, Amino acid, Mechanism of action and Residue. His study in Enfuvirtide is interdisciplinary in nature, drawing from both Viral entry and Cell fusion.

Between 2016 and 2021, his most popular works were:

  • Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. (177 citations)
  • Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2. (50 citations)
  • A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity. (38 citations)

In his most recent research, the most cited papers focused on:

  • DNA
  • Virus
  • Immune system

Yuxian He focuses on Virology, Severe acute respiratory syndrome coronavirus 2, Infectivity, Vaccine efficacy and BALB/c. Yuxian He has included themes like Heptad repeat, Cell fusion and In vivo in his Virology study. His Heptad repeat study incorporates themes from Lipid bilayer fusion and Peptide.

The various areas that he examines in his Cell fusion study include Gp41, Enfuvirtide, Viral load, Viral entry and Simian immunodeficiency virus. There are a combination of areas like Animal model, Protein subunit and Antibody integrated together with his Severe acute respiratory syndrome coronavirus 2 study. His 2019-20 coronavirus outbreak research is multidisciplinary, incorporating elements of Epitope, Monoclonal antibody and Cross neutralization.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Lanying Du;Yuxian He;Yusen Zhou;Shuwen Liu.
Nature Reviews Microbiology (2009)

1522 Citations

Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response

Ilona Glowacka;Stephanie Bertram;Marcel A. Müller;Paul Allen.
Journal of Virology (2011)

965 Citations

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.

Shuwen Liu;Gengfu Xiao;Yibang Chen;Yuxian He.
The Lancet (2004)

612 Citations

Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.

Hongjing Gu;Qi Chen;Guan Yang;Lei He.
Science (2020)

529 Citations

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine.

Yuxian He;Yusen Zhou;Shuwen Liu;Zhihua Kou.
Biochemical and Biophysical Research Communications (2004)

406 Citations

The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection.

Abraham Pinter;William J. Honnen;Yuxian He;Miroslaw K. Gorny.
Journal of Virology (2004)

361 Citations

IFITM proteins restrict viral membrane hemifusion

Kun Li;Ruben M. Markosyan;Yi-Min Zheng;Ottavia Golfetto.
PLOS Pathogens (2013)

353 Citations

Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.

Yuxian He;Hong Lu;Pamela Siddiqui;Yusen Zhou.
Journal of Immunology (2005)

337 Citations

N-Substituted Pyrrole Derivatives as Novel Human Immunodeficiency Virus Type 1 Entry Inhibitors That Interfere with the gp41 Six-Helix Bundle Formation and Block Virus Fusion

Shibo Jiang;Hong Lu;Shuwen Liu;Qian Zhao.
Antimicrobial Agents and Chemotherapy (2004)

319 Citations

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies

Zhongyu Zhu;Samitabh Chakraborti;Yuxian He;Anjeanette Roberts.
Proceedings of the National Academy of Sciences of the United States of America (2007)

312 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Yuxian He

Shibo Jiang

Shibo Jiang

Fudan University

Publications: 321

Lu Lu

Lu Lu

Fudan University

Publications: 108

Lanying Du

Lanying Du

Georgia State University

Publications: 82

Susan Zolla-Pazner

Susan Zolla-Pazner

Icahn School of Medicine at Mount Sinai

Publications: 66

Dimiter S. Dimitrov

Dimiter S. Dimitrov

University of Pittsburgh

Publications: 48

Ralph S. Baric

Ralph S. Baric

University of North Carolina at Chapel Hill

Publications: 47

Shuwen Liu

Shuwen Liu

Southern Medical University

Publications: 45

Stefan Pöhlmann

Stefan Pöhlmann

German Primate Center

Publications: 44

George F. Gao

George F. Gao

Chinese Center For Disease Control and Prevention

Publications: 36

Yusen Zhou

Yusen Zhou

Zhengzhou University

Publications: 33

Joseph Sodroski

Joseph Sodroski

Harvard Medical School

Publications: 29

Kwok-Yung Yuen

Kwok-Yung Yuen

University of Hong Kong

Publications: 26

Peter D. Kwong

Peter D. Kwong

National Institutes of Health

Publications: 26

Michael Farzan

Michael Farzan

University of Florida

Publications: 23

Bo-Jian Zheng

Bo-Jian Zheng

University of Hong Kong

Publications: 23

Andrés Finzi

Andrés Finzi

University of Montreal

Publications: 23

Trending Scientists

Vijay K. Naik

Vijay K. Naik

IBM (United States)

Raffi Codilian

Raffi Codilian

Western Digital (Japan)

Zbigniew Dauter

Zbigniew Dauter

Brookhaven National Laboratory

Loren Dean Williams

Loren Dean Williams

Georgia Institute of Technology

Hong Zhang

Hong Zhang

University of Amsterdam

Philippe Ghosez

Philippe Ghosez

University of Liège

Jean O. Thomas

Jean O. Thomas

University of Cambridge

Giorgio Semenza

Giorgio Semenza

École Polytechnique Fédérale de Lausanne

Robert Chunhua Zhao

Robert Chunhua Zhao

Peking Union Medical College Hospital

Dominique Weil

Dominique Weil

Institut Pasteur

Claudio Grassi

Claudio Grassi

Catholic University of the Sacred Heart

Laurel J. Trainor

Laurel J. Trainor

McMaster University

Andrew Miles

Andrew Miles

University of Toronto

David Nesvorný

David Nesvorný

Southwest Research Institute

Luca Pasquini

Luca Pasquini

European Southern Observatory

Frank W. Wise

Frank W. Wise

Cornell University

Something went wrong. Please try again later.